Gomphocarpus purpurascens A.Richs. (sub-family: Asclepiadaceae, family: Apocynaceae) is an endemic plant in Ethiopia and Eritrea. The chromatographic fractionation of the chloroform:methanol (1:1) leaf extract resulted in the isolation of a cardenolide-type compound named calotropin. Its structure was confirmed based on the 1D-NMR (1H, 13C, and DEPT-135) spectral data along with reported work. This is the first report on the isolation of calotropin from the leaves of G. purpurascens. The n-hexane extract displayed better antibacterial activity against E. coli and P. aeruginosa (8.1 ± 0.0 to 10.8 ± 0.1 mm) up to 12,500 μg/mL concentration. Generally, all the extracts and the isolated compound, calotropin, showed better antibacterial activity against the P. aeruginosa strain than chloramphenicol (7.1 ± 0.2 to 7.3 ± 0.5 mm). The tested chloroform: methanol (1:1) extract indicated a weak antifungal activity against C. albicans compared to ketoconazole 10 µg/disc (17.67 ± 2.52 mm). On the contrary, all the extracts were found to have a good DPPH radical scavenging activity (IC50 values, 1.1-2.7 µg/mL) comparable to ascorbic acid (1.0 µg/mL). The isolated calotropin exhibited a stronger binding capacity (-10.3 kcal/mol) against the P. aeruginosa PqsA (5OE3) protein model than chloramphenicol (-7.0 kcal/mol). This compound was also found to violate Lipinski’s rules of five (with a molecular weight > 500 g/mol) and showed immunotoxicity and cytotoxicity properties. Given that this is a preliminary report, further biochemical investigations would be needed on this G. purpurascens plant to identify additional phytoconstituents with superior efficacy.
No takes yet. Share an insight, caveat, or question.
Kiros et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: